Jasper Therapeutics (JSPR) Income Statement (2019 - 2026)
Income Statement report data from Aug 30, 2019 to Mar 31, 2026 for Jasper Therapeutics (JSPR).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Sep 30, 2019 | Aug 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Cost Of Revenue | 3.62M (-83.93%) | 23M (+140.96%) | 9.35M | - | 9.76M (-61.70%) | 25M (+190.21%) | 8.78M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | 3.62M (-83.93%) | 23M (+140.96%) | 9.35M | - | 9.76M (-61.70%) | 25M (+190.21%) | 8.78M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 5.81M (-48.86%) | 11M (-21.06%) | 14M (-32.12%) | 21M (+31.19%) | 16M (-18.26%) | 20M (+36.72%) | 14M (+27.96%) | 11M (+9.71%) | 10M (-25.58%) | 14M (-6.80%) | 15M (+11.65%) | 13M (+35.58%) | 9.81M (+5.71%) | 9.28M (+2.88%) | 9.02M (+10.81%) | 8.14M (-0.61%) | 8.19M (-5.43%) | 8.66M (+20.45%) | 7.19M (+39.34%) | 5.16M (+16.74%) | 4.42M (-61.09%) | 11M (+151.33%) | 4.52M | - | - | - |
Selling General And Administrative | 5.14M (+14.73%) | 4.48M (-6.28%) | 4.78M (-18.71%) | 5.88M (+4.07%) | 5.65M (+2.54%) | 5.51M (+1.47%) | 5.43M (+15.53%) | 4.70M (-1.47%) | 4.77M (+22.62%) | 3.89M (-13.75%) | 4.51M (-0.44%) | 4.53M (+9.42%) | 4.14M (-7.38%) | 4.47M (+21.14%) | 3.69M (-3.66%) | 3.83M (-16.56%) | 4.59M (+33.82%) | 3.43M (+18.69%) | 2.89M (-11.35%) | 3.26M (+78.14%) | 1.83M (-33.70%) | 2.76M (+85.23%) | 1.49M (+351.52%) | 330K | - | - |
Operating Expenses | 11M (-30.87%) | 16M (-17.37%) | 19M (-29.21%) | 27M (+24.22%) | 22M (-13.80%) | 25M (+27.15%) | 20M (+24.39%) | 16M (+6.10%) | 15M (-15.00%) | 18M (-8.42%) | 19M (+8.58%) | 18M (+27.81%) | 14M (+1.45%) | 14M (+8.18%) | 13M (+6.27%) | 12M (-6.42%) | 13M (+5.79%) | 12M (+19.84%) | 10M (+19.71%) | 8.42M (+34.72%) | 6.25M (-55.74%) | 14M (+134.94%) | 6.01M (+1721.21%) | 330K | - | - |
Depreciation And Amortization | 20K (-97.44%) | 780K | - | - | 280K (0.00%) | 280K (-44.00%) | 500K (+66.67%) | 300K (+3.45%) | 290K (+26.09%) | 230K (-23.33%) | 300K (0.00%) | 300K (+11.11%) | 270K (-41.30%) | 460K (+53.33%) | 300K | - | 220K (-38.89%) | 360K | - | - | 20K | - | - | - | - | - |
Operating Income | ||||||||||||||||||||||||||
Operating Income | -10.95M (-30.87%) | -15.84M (-17.37%) | -19.17M (-29.21%) | -27.08M (+24.22%) | -21.80M (-13.77%) | -25.28M (+27.10%) | -19.89M (+24.39%) | -15.99M (+6.10%) | -15.07M (-15.00%) | -17.73M (-8.42%) | -19.36M (+8.58%) | -17.83M (+27.81%) | -13.95M (+1.45%) | -13.75M (+8.18%) | -12.71M (+6.27%) | -11.96M (-6.42%) | -12.78M (+5.79%) | -12.08M (+19.84%) | -10.08M (+19.71%) | -8.42M (+34.72%) | -6.25M (-55.74%) | -14.12M (+134.94%) | -6.01M (+1721.21%) | -330.00K | - | - |
Ebit | -10.95M (-30.87%) | -15.84M (-17.37%) | -19.17M (-29.21%) | -27.08M (+24.22%) | -21.80M (-13.77%) | -25.28M (+27.10%) | -19.89M (+24.39%) | -15.99M (+6.10%) | -15.07M (-15.00%) | -17.73M (-8.42%) | -19.36M (+8.58%) | -17.83M (+27.81%) | -13.95M (+1.45%) | -13.75M (+8.18%) | -12.71M (+6.27%) | -11.96M (-6.42%) | -12.78M (+5.79%) | -12.08M (+19.84%) | -10.08M (+19.71%) | -8.42M (+34.72%) | -6.25M (-55.74%) | -14.12M (+134.94%) | -6.01M (+1721.21%) | -330.00K | - | - |
EBITDA | -10.93M (-31.00%) | -15.84M (-15.47%) | -18.74M (-29.87%) | -26.72M (+24.16%) | -21.52M (-13.92%) | -25.00M (+28.93%) | -19.39M (+23.58%) | -15.69M (+6.16%) | -14.78M (-15.49%) | -17.49M (-8.24%) | -19.06M (+8.73%) | -17.53M (+28.24%) | -13.67M (-7.95%) | -14.85M (+19.66%) | -12.41M (+19.33%) | -10.40M (-17.20%) | -12.56M (-31.74%) | -18.40M (+439.59%) | -3.41M (-59.45%) | -8.41M (+34.99%) | -6.23M (-78.86%) | -29.47M (+13933.33%) | -210.00K (-93.88%) | -3.43M | - | - |
Other Income / Expenses | ||||||||||||||||||||||||||
Interest Income | 160K (-52.94%) | 340K (0.00%) | 340K (-22.73%) | 440K (-29.03%) | 620K (-34.04%) | 940K (-26.56%) | 1.28M (-11.72%) | 1.45M (+4.32%) | 1.39M (-40.34%) | 2.33M (+62.94%) | 1.43M (-0.69%) | 1.44M | - | 440K (+69.23%) | 260K | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 160K (-52.94%) | 340K (0.00%) | 340K (-22.73%) | 440K (-29.03%) | 620K (-34.04%) | 940K (-26.56%) | 1.28M (-11.72%) | 1.45M (+4.32%) | 1.39M (-40.34%) | 2.33M (+62.94%) | 1.43M (-0.69%) | 1.44M | - | 440K (+69.23%) | 260K | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | -30.00K (-98.63%) | -2.19M (+8.96%) | -2.01M (+2412.50%) | -80.00K (+33.33%) | -60.00K (-33.33%) | -90.00K (+200.00%) | -30.00K (-25.00%) | -40.00K (0.00%) | -40.00K (-84.00%) | -250.00K | 50K (-97.14%) | 1.75M | -310.00K | 590K | - | - | - | -80.00K | - | - | - | - | - | - | - | - |
Net Income | ||||||||||||||||||||||||||
Income Before Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.93M | - | -3.57M | 5.50M (+243.75%) | 1.60M | -210.00K (-93.88%) | -3.43M | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K (0.00%) | -10.00K | - | - | - |
Net Income From Continuing Operations | -1.17M (-87.14%) | -9.10M (-51.44%) | -18.74M (-29.87%) | -26.72M (+25.80%) | -21.24M (-12.66%) | -24.32M (+30.47%) | -18.64M (+27.85%) | -14.58M (+6.19%) | -13.73M (-17.19%) | -16.58M (-5.47%) | -17.54M (+9.08%) | -16.08M (+12.76%) | -14.26M (+7.95%) | -13.21M (+11.38%) | -11.86M (+14.04%) | -10.40M (+370.59%) | -2.21M (-75.61%) | -9.06M (+165.69%) | -3.41M (-59.45%) | -8.41M (-13.74%) | -9.75M (-66.90%) | -29.46M (+14630.00%) | -200.00K (-94.17%) | -3.43M | - | - |
Net Income | -1.17M (-87.14%) | -9.10M (-51.44%) | -18.74M (-29.87%) | -26.72M (+25.80%) | -21.24M (-12.66%) | -24.32M (+30.47%) | -18.64M (+27.85%) | -14.58M (+6.19%) | -13.73M (-17.19%) | -16.58M (-5.47%) | -17.54M (+9.08%) | -16.08M (+12.76%) | -14.26M (+7.95%) | -13.21M (+11.38%) | -11.86M (+14.04%) | -10.40M (+370.59%) | -2.21M (-75.61%) | -9.06M (+165.69%) | -3.41M (-59.45%) | -8.41M (-13.74%) | -9.75M (-66.90%) | -29.46M (+14630.00%) | -200.00K (-94.17%) | -3.43M | - | - |